Celtaxsys Announces Last Patient, Last Visit in Landmark CF Phase 2b Lung Function Preservation Tria
ATLANTA, May 17, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing...
Toothpaste ingredient may bust up cystic fibrosis biofilms
A common antibacterial substance in toothpaste may combat life-threatening diseases such as cystic fibrosis when combined with an with an...
Gastrointestinal Cancers More Common in Adults with CF, Especially After Transplant, Study Finds
Patients with cystic fibrosis (CF) are at higher-than-average risk of developing gastrointestinal cancers, especially those who underwent...
Improving Antibiotic Strategies To Combat Respiratory Infections In Cystic Fibrosis Patients
Cystic fibrosis (CF) is an inherited, progressive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR)...
Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on t
Program to Pursue Broad Label for PTI-428 as an Add-On Therapy to CFTR Modulator Based Treatment BRIGHTON, Mass., May 8, 2018...
Data from Spyryx Biosciences' HOPE-1 Phase 2 Clinical Trial to be Presented in a Late-Breaking O
DURHAM, N.C., May 8, 2018 /PRNewswire/ -- Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel...
CFF ‘Venture Philanthropy’ Model Crucial to CF Breakthroughs and Group’s Success, CEO Says
When the Cystic Fibrosis Foundation (CFF) was established in 1955, most people with cystic fibrosis (CF) didn’t make it to their sixth...
Carlow Cystic Fibrosis sufferer welcoming news that Orkambi will be available for children
A local Cystic Fibrosis sufferer says news that the drug Orkambi will now be available to children is fantastic. The Department of Health...
Myoepithelial Cells Are Reserve Stem Cells For Lung Airway Repair
A new population of stem cells that appear to be important for regenerating the airway following severe injury has been identified by...
Vertex Announces VX-445 Phase 3 Trial Program, Positive Data on VX-561 Combo Regimen
Vertex Pharmaceuticals is launching Phase 3 clinical trials to evaluate the safety and effectiveness of its investigational therapy,...
